NASDAQ OMX

Zageno and Thomas Scientific to Launch New, Fast and Easy Way to Choose and Purchase the Right Lab Products for Each Specific Experiment at Pittcon, Booth 2423

Dela

Continuously innovating to serve its customers better, century-old Thomas Scientific-the third largest and fastest-growing scientific-equipment company is leveraging startup Zageno, the largest and fastest-growing online marketplace dedicated to the research scientist. Zageno's new platform enables scientists to choose the best products to advance science using a ranking score based on millions of unbiased scientific publications; helps customers procure their products through better integration into their existing processes.

 

ORLANDO, Fla. USA and BERLIN, Germany, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Zageno Inc., an online biotech marketplace, and Thomas Scientific - a brand-centric, broad-line life-science-equipment, instrument, furniture, consumable, chemical, and laboratory safety supplier with nearly one million high-quality products - announced a U.S. commercial agreement, where Zageno will feature Thomas Scientific's full spectrum of offerings on the Zageno platform. Products are organized logically by process steps and methods (e.g. preparation gene editing; amplification separation: antibodies detection) so research scientists can search and order Thomas's portfolio of products easily, enabling more focus on performing their experiments instead of gathering supplies.

 

Commenting on its latest addition to its life science vendor partner list, Zageno Cofounder and Chief Revenue Officer Florian Wegener, M.D., M.B.A., Ph.D., said, "With its breadth of product offerings from world-leading brands, century-long commitment to serving the research community, and tireless focus on getting things right for customers - Thomas Scientific was a natural vendor partner for Zageno. We're proud to share their booth at Pittcon 2018, where we'll be honored to demonstrate how Zageno can make it easy for Thomas Scientific customers to save time and make better purchasing decisions for their specific scientific studies."

"We're thrilled to enter into this partnership with Zageno," said Thomas Scientific President and Chief Executive Officer Charles Simmons. "Zageno opened up a valuable channel for new customers, allowing us to optimize the focus of our field-based sales force. As an added benefit, Zageno has been able to integrate with our order-intake process, to make our operations more efficient, and make things easy and seamless for the customer."

In creating a biotech-specialized online marketplace, Zageno's founders recognized that scientific product comparison is different than comparing commercial products. Scientists need more information than is readily available on product packaging; nomenclature often varies from manufacturer to manufacturer making it difficult to compare "apples to apples"; and the stakes are high when choosing wrong. Using a non-optimal product in an experiment can lead to flawed data, poor, or non-reproducible results. To help scientists make the best choice possible, Zageno has created a proprietary application algorithm that not only compares specifications, but also incorporates an independent, unbiased "Zageno Scientific Score," based on millions of scientific publications. For the scientist, this simplifies the comparison process, helping her choose the best performing product for her particular experiment, helping to identify and purchase critical products for the work more reliably and driving down time and cost to scientific result.

"With my background in lean six sigma, I'm very conscious of what constitutes value-add time versus non-value-add time, and in biotech research - time spent performing well-designed, reproducible experiments is the ultimate in value-add time," said Zageno Cofounder and Chief Executive Officer David Pumberger, Ph.D. "We have created this marketplace to streamline supply chains and make it as painless and efficient as possible so that all the researcher has to focus on is his or her end point."

About Thomas Scientific ( www.thomassci.com ; twitter:  @ThomasSci )
Thomas Scientific provides the latest in equipment and supplies to the science community. In accordance to the tradition of the original founders, Thomas Scientific itself offers individualized customer service, innovative scientific equipment, and a comprehensive catalog offering a wide selection of product listings at a great deal. We are a registered contractor for the U.S. Federal Government. Thomas Scientific is committed to offering quality laboratory products while catering to the unique needs of the individual customer. For over a century, our dedication to provide the best in science equipment with personal, efficient service sets Thomas apart from the competition. Whether you work in a lab setting or perform your testing in the field, Thomas Scientific has the products you need. We carry everything you need from all of your favorite and trusted suppliers, including Ansell, Avantor(TM) Performance Materials, Becton Dickinson, Buchi, Corning, GE Healthcare, Globe Scientific, Eppendorf, JG Finneran/Porvair, Kimble, Mettler Toledo, Microflex, MilliporeSigma, Thermo Scientific, Wheaton, and more.

About Zageno Inc. ( www.zageno.com ;  twitter:  @ZAGENOteam )
Founded in 2015, Zageno is eliminating bottlenecks to breakthrough science and research through curated connections linking scientists and their institutions' procurement offices with leading life science vendors. World-renowned academic and government research facilities, global pharmaceutical companies, and biotechs large and small are already users of our unique online biotech marketplace, currently comprising more than three million products. What do we do? 1) We help scientists choose the optimal laboratory kits and materials for each unique experiment setup. 2) We make purchasing transactions more efficient for both buyers and sellers. 3) For our vendor partners, we provide a valuable, expanded sales channel. Our growing Zageno team of 50 in Boston, USA, and Berlin, Germany, includes experts in science, e-commerce, systems integration, and customer support to enable smarter, faster processes - allowing more time and resources for value-added science and better research results.

 

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/04a8c6dc-312c-4acb-826d-f8926c736be8

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7c42128a-faa4-40d4-aa2e-f662aa0a81dc

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/6fb6f0ad-059d-4529-b2c8-a32e70601948

Caroline Grossman for Zageno
Mirepoix LLC
(781) 771-5579
Caroline@mirepoixllc.com

Diane Skala for Thomas Scientific
Thomas Scientific
(856) 832-3296
DianeS@thomassci.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ZAGENO, Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Hoylu AB: UNITED STATES ARMY SELECTS HOYLU FOR DIGITAL COLLABORATION SOLUTIONS26.9.2018 08:30Pressmeddelande

Malmo, Sweden, September 26, 2018 - Hoylu, a leading enterprise collaboration company announced today that the United States Army has selected Hoylu Software and the large format HoyluWall system as a digital workspace tool for workspace collaboration, process planning and ideation. Hoylu software will be used to modify, save, print and communicate between teams at remote locations and allow for collaborative analysis. The order will be delivered in Q3 2018 and represents a deal value of SEK 528,000 in product and software revenue and presents ongoing opportunities to expand within the government sector. This system will be installed at the Picatinny Arsenal in New Jersey, the US Army's primary R&D arm for armament and munitions systems. Picatinny Arsenal is the Joint Center of Excellence for Guns and Ammunition, providing products and services to all branches of the U.S. military. Picatinny Arsenal has partnerships with a variety of universities and industry partners, involving them i

Hoylu AB: USA:s armé väljer Hoylu för digitala samarbetslösningar26.9.2018 08:30Pressmeddelande

Malmö, Sverige, 26:e september 2018 - Hoylu, ett ledande företag inom digitala samarbetslösningar tillkännagav idag att USA:s armé har valt Hoylus mjukvara och storformats Hoylu Wall-system som verktyg för digitalt samarbete, delade arbetsytor, processplanering och idégenerering. Hoylus mjukvara kommer användas till att modifiera, spara, skriva ut och stödja samarbete mellan team på olika platser samt möjliggöra kollaborativ analys. Ordern kommer levereras under tredje kvartalet 2018 och har ett sammanlagt värde på SEK 528 000 för hård- och mjukvara. Ordern visar på ökande möjligheter att växa inom statlig och offentlig verksamhet. Systemet kommer installeras på Picatinny Arsenal i New Jersey, USA:s armés primära R&D-enhet för vapen- och ammunitionssystem. Picatinny Arsenal är ett s.k. "Joint Center of Excellence" för vapen och ammunition och de tillhandahåller produkter och tjänster åt alla grenar av USA:s armé. Picatinny Arsenal har också samarbeten med en mängd olika universitet och

Bergman & Beving AB: Aktierelaterat incitamentsprogram25.9.2018 10:00Pressmeddelande

Pressrelease Aktierelaterat incitamentsprogram Det av årsstämman 2018 beslutade aktierelaterade incitamentsprogrammet som omfattar 16 ledningspersoner om maximalt 210 000 köpoptioner på återköpta aktier av serie B har fulltecknats. Köpoptionerna kommer att överlåtas till ett pris av 7,10 SEK per köpoption vilket motsvarar marknadsvärde enligt en extern oberoende värdering utförd i enlighet med Black-Scholes-modellen. Lösenkursen för köpoptionerna uppgår till 117,90 SEK motsvarande 120 procent av den genomsnittliga aktiekursen under mätperioden 24 augusti - 7 september 2018. Varje köpoption berättigar till förvärv av en återköpt aktie av serie B under perioden från och med den 13 september 2021 till och med den 10 juni 2022. Stockholm den 25 september 2018 Bergman & Beving AB (publ) För ytterligare information kontakta: Peter Schön, CFO, telefon 070-339 89 99 Informationen lämnades, genom ovanstående kontaktpersoners försorg, för offentliggörande den 25 september 2018 kl. 10:00 CET. Ber

Bergman & Beving AB: Share-based incentive scheme25.9.2018 10:00Pressmeddelande

Press Release Share-based incentive scheme The share-based incentive scheme resolved by the 2018 Annual General Meeting where 16 members of senior management were offered to acquire up to 210,000 call options on repurchased class B shares has been fully subscribed. The call options will be transferred at a price of SEK 7.10 per call option, equivalent to the market value according to an external independent valuation, applying the Black-Scholes-model. The redemption price of the call options amounts to SEK 117.90, equivalent to 120 percent of the volume-weighted average of the paid market price for the shares during the period from 24 August to 7 September 2018, inclusive. Each call option entitles the holder to acquire one repurchased class B share during the period from 13 September 2021 to 10 June 2022, inclusive. Stockholm den 25 September 2018 Bergman & Beving AB (publ) Contact information Peter Schön, CFO, Bergman & Beving AB, Tel: +46 70 339 89 99 The information was submitted f

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum